New INN nomenclature for monoclonal antibodies
Lancet
.
2022 Jan 1;399(10319):24.
doi: 10.1016/S0140-6736(21)02732-X.
Authors
Raffaella Balocco
1
,
Sofia De Sousa Guimaraes Koch
2
,
Robin Thorpe
3
,
Karin Weisser
4
,
Sarel Malan
5
Affiliations
1
INN Unit, WHO, Geneva, CH-1211, Switzerland. Electronic address: baloccor@who.int.
2
INN Unit, WHO, Geneva, CH-1211, Switzerland.
3
Welwyn, UK.
4
Paul Erlich Institute, Langen, Germany.
5
School of Pharmacy, University of the Western Cape, Cape Town, South Africa.
PMID:
34973717
DOI:
10.1016/S0140-6736(21)02732-X
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal*
Antineoplastic Agents, Immunological*
Humans
Substances
Antibodies, Monoclonal
Antineoplastic Agents, Immunological
Grants and funding
001/WHO_/World Health Organization/International